Introduction
Oral cancer, predominantly oral squamous cell carcinoma (OSCC), is the most common head and neck cancer worldwide, with more than 300,000 new cases being diagnosed annually (1, 2) . Despite advances in therapy, the 5-year survival rate for OSCC has not improved markedly over the past years, due to late diagnosis and frequent loco-regional recurrences at the primary site and the metastatic neck lymph node after treatment (3, 4) . Therefore, molecular signatures that predict disease prognosis and a deeper understanding of the molecular mechanisms of OSCC tumorigenesis are urgently needed to improve therapeutic efficacy, as well as to design more effective treatment strategies for OSCC. Epidemiologic studies have shown that tobacco usage, alcohol consumption, betel quid chewing, and human papillomavirus infection are the most common environmental risk factors for the development of oral cancer (5, 6) . Among these factors, betel quid has been recognized as the major contributing factor for OSCC in Southeast Asia, including Taiwan (7). However, the molecular mechanisms involved in the pathogenesis of betel quid chewing-associated oral cancer remain largely unknown. Author Manuscript Published OnlineFirst on October 28, 2014; DOI: 10.1158/0008-5472.CAN- and causing either translational repression or degradation of the mRNA (8, 9) . Several mechanisms leading to abnormal expression of miRNAs in cancer have been reported, such as chromosome rearrangements, genomic copy number change, as well as epigenetic modifications (10) (11) (12) . More recently, few evidences have revealed that miRNAs were transcriptionally inactivated by CpG island hypermethylation in several types of cancers (13, 14) , suggesting epigenetic modification to be a crucial factor for determining the expression of miRNAs in human cancers.
Here, we present the results of genome-wide miRNA expression profiling in 40 OSCC specimens and their matched non-tumorous epithelial counterparts. Our study identified that a total of 84 miRNAs are differentially expressed in OSCC specimens.
We provides data showing that epigenetic silencing of miR-329 and miR-410, two miRNAs from 14q32.2 cluster, may contribute to Wnt-7b overexpression and to activate Wnt/β-catenin signaling pathway, thus promoting proliferation and invasion in OSCC tumorigenesis. Finally, the dysregulation of the maternally expressed gene-3 (Meg-3)/miR-329&410/Wnt-7b/β-catenin signaling axis may result from exposure to betel quid chewing. 
Materials and Methods

Cell culture, antibodies, vectors, and reagents
Human oral keratinocytes (HOK) was purchased from ScienCell (Carlsbad, CA, USA) and cultured in oral keratinocyte medium (Carlsbad, CA, USA) according to the manufacturer's instructions. OSCC cells, including DOK, FaDu, OC-3, OEC-M1, SCC-4, SCC-9, SCC-15, SCC-25, Tw2.6 and YD-15 were routinely cultured as previously described (15) . All cells were authenticated by morphology and growth characteristics, tested for Mycoplasma and frozen, and cultured at 37°C in a 5% CO 2 atmosphere and maintained in 10% fetal bovine serum (FBS, Kibbutz BeitHaemek, Israel) within 3 months of resuscitation from the frozen stock, with lower than 20 passages. Wnt-7b antibody (GTX114881) was purchased from Genetex, CCND-1 antibody (2261-S) was purchased from Epitomics, and anti-α-tubulin antibody (MS-581) was purchased from NeoMaker. Antibodies specific for phospho-β-catenin (8814), anti-β-catenin (9582), phospho-serine-9-GSK-3β (9336) GSK-3β (9832), and myc (9420) were purchased from Cell signaling. The miRNA inhibitors (AM) and miRNA mimics (PM) were chemical modified RNA molecules and obtained from Ambion. Wnt-7b siRNA were purchased from Dharmacon. Human Wnt-7b expression vector was purchased from OriGene. The miRNA over-expression vector pLemiR was obtained from Open-Biosystem. TOP/FOP flash TCF reporter vectors were kindly donated by Dr. C-C. Chang (16 
Clinical samples and patient characteristics
Paired tumor specimens and their adjacent non-tumorous epithelia were received curative surgery from 1999 to 2010 at the National Cheng Kung University Hospital.
Fresh frozen tissues were preserved in liquid nitrogen until use. The American Joint Committee on Cancer staging system was used for tumor staging (17) . The study protocol was reviewed and approved by the Institutional Human Experiment and Ethic Committee (HR-97-100).
Microarray profiling
Total RNA and genomic DNA for microarray analysis were isolated from OSCC frozen tissues using the miRNeasy Mini Kit (Qiagen) and QIAamp DNA Mini Kit (Qiagen) according to the manufacturer's protocol. Gene expression profiling was performed using the whole-genome DASL HumanRef-8-v3 chip and miRNA expression profiling was performed using the Human-v2 MicroRNA Expression BeadChips (Illumina, Inc.). Microarray data processing and analysis were done using Illumina BeadStudio software. Microarray data are available in GEO under accession number GSE37991 for genes expression and GSE45238 for miRNA expression.
Western blot and immunofluorescence assays
Nuclear and cytosolic extracts were obtained according to the REAP method (18) and western blots were performed as previous described (19 
Plasmids construction, virus production, and infection of target cells
To generate the sponge-miR-329 and -410 plasmids, a synthetic miRNA sponge sequence containing 4 specific miRNA binding sites was cloned into the pGIPZ lentivirus plasmid (Open-Biosystem). The miRNA-sponge sequences were based on 
RNA extraction and quantitative RT-PCR
Total RNA was extracted using TriZol reagent (Invitrogen) and cDNA was synthesized using random hexamer primers and SuperScript III reverse transcriptase (Invitrogen) for PCR or quantitative-PCR (qPCR). For the miRNA assay, specific stem-loop RT primers were designed (21) and used to perform reverse transcription.
All primers used in this study are summarized in the "Supplementary Materials and Methods". The luciferase assay was performed 48 h post transfection with a control vector or a vector containing part of the 3′-UTR of the Wnt-7b using the dual luciferase assay (Promega) as described by the manufacturer's protocol. Luminometry readings were obtained using an Orion L luminometer (Berthold).
Luciferase assay
Functional assays
All OSCC cells used in the functional assays were transfected with the indicated plasmids and stable colonies were selected. The functional assays such as proliferation and invasion assay were performed as described (15) . For the clonogenic assay, 500 cells were seeded into 6-well plates and cultured for 7 days. Colonies were fixed in 1.0% crystal violet (Merck) and visible colonies were counted.
Bisulfite sequencing PCR (BSP)
Genomic DNA, extracted using the DNA extraction kit (Qiagen), was bisulfite-modified by EZ-DNA Methylation-Gold Kit (Zymo Research) according to the manufacturer's instructions. The bisulfite-modified DNA was used to amplify a 640-bp product situated within the Meg-3 promoter region and cross exon 1 (-444 to +196 sites) using the Meg-3-CpG1-F and Meg-3-CpG1-R primer sets. The sequenced DNA region for the Meg-3 promoter was confirmed using an automated sequencer (ABI automated sequencer). 
Animal studies
Statistical analysis
Between-group differences were analyzed by 2-tailed Student's t test. All statistical analyses were performed using GraphPad Prism Ver. 4 was denoted a statistical significance.
Results
Global miRNA profiling of OSCC patients.
In order to identify deregulated miRNAs in oral cancer, miRNA expression profiles were generated from 40 pairs of OSCC specimens (Supplementary Table S1) and their corresponding non-tumorous epithelia by using a custom microarray platform. We further identified 84 miRNAs that were differentially expressed with Meg-3 represents a large noncoding RNA as the initial transcript of Dlk1-Dio3 locus (22) . The loss of Meg-3 expression and chromosome-14q32.2 miRNAs were consistently found in various types of tumors (23, 24) . In order to determine whether Meg-3 and other neighboring genes have altered expression levels, we performed a genome-wide expression array using the same set of 40 pairs from the OSCC specimens. Meg-3 expression was significantly downexpressed as well as the other neighboring protein-coding genes, Dlk1 and Dio3 (Fig.1A) . Using qRT-PCR, we verified that the expression level of Meg-3 transcript was markedly reduced in OSCC patients (Fig.1B ) and in OSCC cell lines compared to the normal keratinocyte HOK ( Fig.1C; Fig.1D ). Furthermore, we also observed significant downexpression of the 14q32.2 miRNAs in OSCC patients and cell lines ( Fig.1E; Fig.1F ). These results indicate that the expression of the Meg-3 and cluster miRNAs which locate on the Dlk1-Dio3 imprinted region are coordinately regulated in OSCC.
miRNAs target the activator of the Wnt signaling pathway.
Wnt signaling pathway has been reported significantly enriched in the Meg3-null mice by microarray analysis (25 combined with microarray data to search for putative miRNAs that might bind to Wnt-7b mRNA. We identified two miRNAs, miR-329 and miR-410, could potentially target Wnt-7b. Fig.2A illustrates the predicted miRNA binding sites in the 3′-UTR of Wnt-7b. A significantly negative correlation between the miRNAs and the Wnt-7b was found in OSCC cells ( Fig.2B; Fig.2C ). To validate miRNA-target protein interactions, the Wnt-7b 3′-UTR fragment, containing the wild type or mutant miRNA binding sequence, was cloned into the Renilla luciferase reporter and then cotransfected with miR-329 or miR-410 mimics (PM) into OEC-M1 cells. Both miRNA significantly reduced the luciferase activity with respect to the scrambled sequence; however, mutations in the miR-329 or miR-410 binding sites resulted in a complete reversal of the luciferase activity (Fig.2D) . Subsequently, the overexpression of individual miR-PM induced a marked reduction of Wnt-7b protein levels (Fig.2E, left panels) . Otherwise, the depletion of miR-329 or miR-410 with miRNA inhibitor (AM) caused the upregulation of Wnt-7b (Fig.2E, right panels) , establishing Wnt-7b as a target of both miR-329 and miR-410. However, there is no toxic effect in our miRNA overexpression system ( Supplementary Fig. S2 ). To consolidate our findings, we correlated the expression level of miRNAs (Fig-2F) to Wnt-7b mRNA using clinical OSCC specimen and found a strong inverse correlation between the expression levels of miR-329/or miR-410 and Wnt-7b (Fig.2G) .
miR-329 and -410 modulate the Wnt/β-catenin signaling pathway.
Because miR-329 and miR-410 directly target Wnt-7b, suggested the possibility that these two miRNAs might regulate Wnt/β-catenin signaling. To test this hypothesis, the Wnt signaling reporter was validated by Top-Flash/Fop-Flash assay (16) . LiCl was used to stimulate Wnt/β-catenin signaling (26) and acts as a positive control (Fig.3A, left) . Overexpression of miR-PMs suppressed TCF/LEF1 transcriptional activity (Fig.3A, middle) ; in contrast, the overexpression of miR-AM increased TCF/LEF1 transcriptional activity (Fig.3A, right) . Moreover, the overexpression of miR-PMs resulted in a decreased amount of active nuclear β-catenin in nucleus (Fig.3B) .
Next, we introduced cells with miR-329 or miR-410 and examined the phosphorylation status of β-catenin (active) and GSK-3β (inactive). As expected, miR-PMs markedly suppressed the phosphorylation of GSK-3β and β-catenin in OEC-M1 cells, consequently, caused a downregulation of cyclin-D1 and c-Myc (Fig.3C ) and increase in β-catenin translocation to the cell membrane (Fig.3F) .
Similar results were observed for another SCC-15 cell line (Supplementary Fig. S3A ).
Conversely, the silencing of endogenous miRNAs with miR-AMs caused an opposite 
effects in OC-3 and SCC-4 cells ( Fig.3C; Supplementary Fig. S3A ). To further investigate the impact of Wnt-7b on the Wnt/β-catenin signaling pathway, we used two target-specific siRNAs specifically targeting Wnt-7b. A marked decrease in inactive GSK-3β, active β-catenin, c-Myc and cyclin-D1 were observed after Wnt-7b knockdown (Fig.3D) . Most notably, the si-Wnt-7b overexpression suppressed TCF/LEF1 transcriptional activity (Fig.3E) and increase in β-catenin translocation to the cell membrane ( Supplementary Fig.S3B ).
miR-329 and miR-410 reduce the proliferation and invasiveness of OSCC cells.
To understand the biological functions of miR-329 and miR-410 in OSCC cells, we then transfected OSCC cell lines with miRNA expression vector (pLemiR) or miRNA-sponge vector. We found that miR-329 or miR-410 in OEC-M1 stable cells was significantly increased when compared with the corresponding pLemiR-control cells (Fig.4A) . The tumor cell proliferation, monolayer colony formation, and invasive ability were notably decreased in OEC-M1 stable cells that were overexpressing miR-329 or miR-410 ( Fig.4B; Fig.4G; Fig.4H; Fig.4I ). To determine if Wnt-7b acts as a functional target of miR-329 or miR-410 in OSCC cells, we transferred a vector-based Wnt-7b without 3′-UTR into miR-329-or miR-410-overexpressing stable cells (Supplementary Fig.S4A ). The ability of 
proliferation, colony formation, and invasion were recovered after exogenous expression of Wnt-7b in miRNA-overexpression stable cells ( Fig.4C; Fig.4H; Fig.4I ).
As expected, tumor cell proliferation and monolayer colony formation were significantly increased in OC-3 cells that were stably expressing the miR-329 and miR-410 sponge vector ( Fig.4D; Fig.4E; Fig.4F) . Importantly, the knockdown of Wnt-7b in the miRNA-sponge stable OC-3 cells could totally block miR-329-and miR-410-induced proliferation and monolayer colony formation ( Fig.4F ; Supplementary Fig.S4B-S4D ). Furthermore, overexpression of miR-PM in OSCC cell lines have a dose-dependent pattern on secreted Wnt-7b protein level in culture medium ( Supplementary Fig.S4E ).
Effects of miR-329 and miR-410 suppress tumorigenicity in a xenograft model.
To further confirm the above findings, an in vivo xenograft mouse model was carried out by subcutaneous injection of miRNA-overexpressing stable OEC-M1 cells ( Fig.5A; Fig.5D ). As compared with the vector control (NS) group, the average tumor weight ( Fig.5B; Fig.5E ) and the average tumor volume ( Fig.5C; Fig.5F ) were significantly reduced in the miRNA overexpression group. Moreover, we detected the expression of miRNA, Wnt-7b, and active-β-catenin in the harvested tumor tissues.
Similar to the in vitro results, the levels of miRNAs were significantly increased in Fig.S5 ). The expression levels of the Wnt-7b and active-β-catenin proteins were all decreased in the miRNA overexpression groups ( Fig.5G; Fig.5H ). Similar results are represented in SCC-15 xenograft experiment (Supplementary Fig.S6 ).
Wnt-7b correlates with lymphovascular invasion in OSCC.
To explore the potential role of Wnt-7b, we first investigated the expression patterns of the Wnt-7b in 83 OSCC specimens, and then correlated with the clinical parameters of these patients. (n=58, score 2 and 3) according to their tumor Wnt-7b staining intensity scores (Fig.6A, right lower panel) . When survival was compared between these 2 groups (Fig.6B) , patients with high Wnt-7b expression tended to have a less favorable relapse-free survival and had a significantly poorer disease-specific survival rate compared to patients with low tumor Wnt-7b expression.
Loss of MEG-3 and its encoded miRNAs in OSCC cells with epigenetic regulation.
The results described above indicate that the dysregulation of miR-329 and miR-410 has profound impacts on multiple functions in OSCC tumorigenesis, however, little is known about the regulatory mechanisms. Recent reports showed that epigenetic modification of the Meg-3 differentially methylated region (Meg3-DMR) in inactivation of the Meg-3 and 14q32.2 miRNAs may play a significant role in human tumors (24, 27) . Computational analysis identified a putative CpG island across the transcriptional start site of the Meg-3 transcript (Fig.7A) resulted in the re-expression of the Meg-3 transcript (Fig.7B) , miR-329 and miR-410 (Fig.7C) . We further analyzed the degree of methylation of the Meg-3-DMR in 11 OSCC patients; the average methylation percentage of the Meg-3-DMR in tumors (86.1%) was higher than that (68%) in their adjacent normal tissue (Fig.7D) . Next, we determined the effect of arecoline, a major component of betel nut alkaloids, on the expression of Meg-3 and the 14q32.2 miRNAs. We found that arecoline treatment could reduce the expression level of Meg-3 and the 14q32.2 miRNAs in a time-dependent pattern in HOK cells ( Fig.7E; Fig.7F Fig.S7A ). Furthermore, miR-PM could decrease the arecoline-induced proliferation rate in DOK cells (Supplementary Fig.S7B ). Using gene set enrichment analysis to predict transcription factor in miRNA overexpression OEC-M1 cells, we significantly enriched the CTNNB1 (β-catenin) in our transcription factor category (Supplementary Table S5 ). Taken together, these results emphasize that betel quid may contribute to oral carcinogenesis through the silencing of tumor suppressor miRNAs, consequently, activating the Wnt/β-catenin signaling pathway. 
Discussion
Aberrant miRNA expression patterns have been widely reported in various cancer types (29) (30) (31) (32) . In this study, we identified a large group of OSCC-associated miRNA clusters located on the chromosome 14q32.2 region and within a parentally imprinted domain designated Dlk1-Dio3 (33). Meg-3 represents a lncRNA as its transcript from the Dlk1-Dio3 region that could initiate at the Meg-3 promoter (22) . The loss of Meg-3 expression has been found in various types of tumors (23, 24) , which is caused by the loss of gene copy number and/or CpG methylation (22) . Three pieces of evidence support the epigenetic regulation mechanism of Meg-3 expression in our OSCC model. First, BSP analysis confirmed an increased methylation of the CpG islands within the Mrg-3-DMR in OSCC cells (95.5%~97.1%) in comparison with the normal HOK (40.71%) ( Fig.7A; Fig.7B ), which is responsible for the expression of Meg-3 (Fig.2C) . Second, the treatment of OSCC cells with a demethylating agent alone enhanced Meg-3 expression more than with HDAC inhibitor alone (Fig.7B) .
Third, the regulation of imprinting genes in this region is thought to be tightly mediated by an intergenic differentially methylated region (IG-DMR) and . This indicates that Meg-3-DMR and IG-DMR function as imprinting control centers with a hierarchical interaction for a methylation pattern (28) . Taken together, our data indicate that Meg-3 can be modulated by a methylation 
mechanism in OSCC cells and consistent with other reports (34) (35) (36) . Additionally, it is important to emphasize that the expression of the 14q32.2 miRNAs and Meg-3 transcripts are regulated by the DMR methylation status (37, 38) , which result in DNA conformation change and long-range epigenetic silencing in this region.
However, the regulation of miRNAs from this cluster is complex and needs to be explored further.
Meg3 knockout mice have been generated to identify targets and potential functions of this noncoding gene in embryonic development and tumorigenesis (25) . (Fig.4) , confirming our conclusion that Wnt-7b is a functional mediator for miR-329 and miR-410 in OSCC cells. Although patients with high level miR-329 or miR-410 expression tended to have a less favorable relapse-free survival and disease-specific survival rate compared to patients with low tumor miRNA expression (data not shown). The poor result may be due to the smaller sample size. However, Wnt-7b has a strong inverse correlation between the expression levels of miR-329 and miR-410 in OSCC specimen (Fig.2G) . These two miRNA also regulate Wnt/β-catenin signaling in vitro and in vitro model (Fig.3 and Fig.5 ), suggesting that miR-329 and miR-410 still playing important role in OSCC carcinogenesis.
As mentioned above, this study showed that the loss of Meg-3 transcript and 14q32.2 miRNA expression was significantly correlated with Meg-3 promoter hypermethylation ( Fig.7A-7C arecoline exposure in HOK cells ( Fig.7E; Fig.7F ), suggesting that betel nut chewing may contribute to the downregulation of Meg-3 and the partial of 14q32.2 miRNAs.
Several lines of evidence indicate that hypermethylation may be involved in the pathogenesis of oral cancer associated with betel quid chewing (45, 46) . Therefore, it is reasonable to suppose that the silencing of the 14q32.2 miRNAs, which would seem to be correlated with Meg-3 promoter hypermethylation, is related to betel quid chewing and might be a significant event in oral carcinogenesis.
In conclusion, our findings define the relationship between the miR-329/-410 and the Wnt/β-catenin pathway, which implies functional mechanisms in oral carcinogenesis.
Importantly, the dysregulation of the Meg-3/miR-329&410/Wnt-7b/β-catenin signaling axis may result from exposure to betel quid chewing (Fig.7G) . To the best of our knowledge, this is the first investigation suggesting that betel quid chewing has a significant impact on Meg-3/miR-329&410 expressions in OSCC. A further study focusing on these alternative mechanisms is now warranted. 
